Your Article Summary
See Latest ArticlesPhase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment-Naive Subjects with HIV-1 Infection
The Journal of Infectious Diseases, 09/24/08
Landovitz RJ et al. - VCV administered with dual NRTIs in treatment-naive subjects with HIV-1 infection had increased rates of virologic failure, compared with efavirenz plus dual NRTIs. No treatment-limiting toxicity was observed. Study of higher doses of VCV as part of combination therapy is warranted.
Related Articles
Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09
Relevance Score: 95%
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Relevance Score: 95%
Mediators of HIV-related stigma and risk behavior in HIV infected young women
AIDS Care, 11/12/09
Relevance Score: 94%
Sperm May Play Leading Role In Spreading HIV
ScienceDaily, 10/27/09
Relevance Score: 94%
Female sex work and HIV risks in Croatia
AIDS Care, 10/29/09
Relevance Score: 93%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/20/09
Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy Alone in Human Immunodeficiency Virus Infection
The American Journal of the Medical Sciences, 12/19/09
Management of HIV-Infected Patients With ESRD
Advances In Chronic Kidney Disease , 12/18/09